Clinical Trials for Novatek Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Novatek Pharmaceuticals

Clinical Trials (2)

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

PHASE1Recruiting

35 participants

Started: Mar 5, 2025 · Completed: Sep 1, 2030

1 condition2 sponsors1 location

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

PHASE1Active, not recruiting

15 participants

Started: Dec 15, 2022 · Completed: Jun 30, 2026

4 conditions2 sponsors1 location